Mednow Inc Stock Fundamentals
| MDNWF Stock | USD 0.02 0.00 0.00% |
Mednow Inc fundamentals help investors to digest information that contributes to Mednow's financial success or failures. It also enables traders to predict the movement of Mednow Pink Sheet. The fundamental analysis module provides a way to measure Mednow's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mednow pink sheet.
Mednow |
Mednow Inc Company Return On Asset Analysis
Mednow's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mednow Return On Asset | -0.55 |
Most of Mednow's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mednow Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Mednow Inc has a Return On Asset of -0.5537. This is 93.67% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The return on asset for all United States stocks is notably higher than that of the company.
Mednow Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mednow's current stock value. Our valuation model uses many indicators to compare Mednow value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mednow competition to find correlations between indicators driving Mednow's intrinsic value. More Info.Mednow Inc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mednow's earnings, one of the primary drivers of an investment's value.Mednow Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mednow's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Mednow could also be used in its relative valuation, which is a method of valuing Mednow by comparing valuation metrics of similar companies.Mednow is currently under evaluation in return on asset category among its peers.
Mednow Fundamentals
| Return On Equity | -1.9 | |||
| Return On Asset | -0.55 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 4.96 M | |||
| Shares Outstanding | 21.57 M | |||
| Shares Owned By Insiders | 47.93 % | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 0.18 X | |||
| Revenue | 16.64 M | |||
| Gross Profit | 2.78 M | |||
| EBITDA | (28.12 M) | |||
| Net Income | (29.56 M) | |||
| Cash And Equivalents | 9.39 M | |||
| Cash Per Share | 0.44 X | |||
| Total Debt | 30 K | |||
| Debt To Equity | 0.28 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | 0.09 X | |||
| Cash Flow From Operations | (16.09 M) | |||
| Earnings Per Share | (0.71) X | |||
| Market Capitalization | 10.33 M | |||
| Total Asset | 18.13 M | |||
| Net Asset | 18.13 M |
About Mednow Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mednow Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mednow using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mednow Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Mednow is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Mednow Pink Sheet
Mednow financial ratios help investors to determine whether Mednow Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mednow with respect to the benefits of owning Mednow security.